| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11026118 | Clinica Chimica Acta | 2018 | 6 Pages |
Abstract
Both PLAC® mass and PLAC® activity tests are effective but the CHAPS modified PLAC® mass test has no or less utility in the risk assessment of CVD. The ratio of Lp-PLA2 by either PLAC® mass or PLAC® activity over ApoA1 or (Apo A1â¯+â¯Apo B) synergistically enhance the risk assessment power for ischemic stroke.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Shaoqiu Zhuo, Chong Yuan,